⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMRN News
BioMarin Pharmaceuticals Inc
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight
globenewswire.com
ADAG
ABBV
BIIB
BMRN
BLRX
CNSP
CYCN
GEN
GILD
GRAF
GSK
HSIC
HUBS
IBIO
INCY
JAZZ
JNJ
MAGN
MARA
MRK
NVS
OMER
PFE
PRGS
REGN
RGNX
SRPT
TENB
TGLS
TGTX
TNDM
TXG
VRTX
4D Path Announces Strategic Financing and Appointment of Katherine Vega Stultz and Robert J. Hombach to Its Board of Directors
businesswire.com
BMRN
BAX
Form 8-K
sec.gov
XYZ
BSQKZ
PINS
BMRN
LEVI
Form 8-K
sec.gov
BMRN
BioMarin Reports First Quarter 2026 Financial and Operating Results
prnewswire.com
BMRN
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting
prnewswire.com
BMRN
Form 8-K
sec.gov
BMRN
BioMarin Completes Acquisition of Amicus Therapeutics
prnewswire.com
BMRN
Form 8-K
sec.gov
BMRN
Form 8-K
sec.gov
FOLD
BMRN